Historical Stock Chart
2 Months : From Jun 2019 to Aug 2019
--Novartis AG (NVS) said it would supply U.S. pharmacies with its pre-filled Symjepi epinephrine shots, amid a shortage of Mylan NV's (MYL) EpiPens, Reuters reports Tuesday.
--Novartis said they would charge a wholesale price of $250 for two adult-dose syringes, the report said, adding Mylan charges $300 for its authorized generic.
--A unit of Pfizer Inc. (PFE) produces all EpiPens sold across the globe at a single plant, which had been experiencing manufacturing problems, the report said.
Full story: https://www.reuters.com/article/us-novartis-epipen-launch/novartis-to-sell-epinephrine-shot-in-u-s-pharmacies-amid-epipen-shortage-idUSKCN1U418X
--Write to Stephen Nakrosis at email@example.com
(END) Dow Jones Newswires
July 09, 2019 19:15 ET (23:15 GMT)
Copyright (c) 2019 Dow Jones & Company, Inc.